Piramal Pharma Ltd - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
23 May 2024
Disclosure under Regulation 30 of the SEBI (listing Obligations and DIsclsoure Requirements) Regulations, 2015 - Successful closure of US FDA Inspection of Piramal Pharma''s manufacturing facility located at Lexington, USA.
Source:
BSE India